CSPC Pharmaceutical Group Limited Sustainability Profile
CSPC Pharmaceutical Group Limited, often referred to as CSPC, is a prominent player in the global pharmaceutical industry, headquartered in the United States. Founded in 1997, the company has established a strong presence in major operational regions, including Asia and Europe, focusing on the research, development, manufacturing, and marketing of a diverse range of pharmaceutical products. CSPC is renowned for its innovative core offerings, which include prescription medications, over-the-counter drugs, and active pharmaceutical ingredients. The company’s commitment to quality and research excellence has positioned it as a leader in therapeutic areas such as oncology, cardiovascular health, and central nervous system disorders. With numerous accolades and a robust market position, CSPC continues to make significant strides in advancing healthcare solutions worldwide.
DitchCarbon Score
How does CSPC Pharmaceutical Group Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CSPC Pharmaceutical Group Limited's score of 8 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CSPC Pharmaceutical Group Limited's reported carbon emissions
CSPC Pharmaceutical Group Limited, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that CSPC may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives. In the context of the pharmaceutical industry, companies are increasingly expected to adopt robust climate strategies and transparency in emissions reporting. Without specific emissions data or reduction initiatives, CSPC Pharmaceutical Group Limited may face challenges in aligning with industry best practices and stakeholder expectations regarding sustainability and climate action.
How Carbon Intensive is CSPC Pharmaceutical Group Limited's Industry?
How Carbon Intensive is CSPC Pharmaceutical Group Limited's Location?
CSPC Pharmaceutical Group Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
CSPC Pharmaceutical Group Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.